SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001144204-19-021965
Filing Date
2019-04-29
Accepted
2019-04-29 17:00:21
Documents
5
Period of Report
2019-06-10
Effectiveness Date
2019-04-29

Document Format Files

Seq Description Document Type Size
1 DEF 14A tv519967_def14a.htm DEF 14A 599066
2 GRAPHIC tv519967_img01.jpg GRAPHIC 27312
3 GRAPHIC tv519967_img02.jpg GRAPHIC 12693
4 GRAPHIC tv519967_img03.jpg GRAPHIC 146416
5 GRAPHIC tv519967_img04.jpg GRAPHIC 123871
  Complete submission text file 0001144204-19-021965.txt   1028314
Mailing Address 999 SKYWAY ROAD SUITE 150 SAN CARLOS CA 94070
Business Address 999 SKYWAY ROAD SUITE 150 SAN CARLOS CA 94070 6502607120
IOVANCE BIOTHERAPEUTICS, INC. (Filer) CIK: 0001425205 (see all company filings)

IRS No.: 753254381 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36860 | Film No.: 19776839
SIC: 2836 Biological Products, (No Diagnostic Substances)